Previous
Next

Retrophin is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening, and for which there are currently limited patient options.

Retrophin is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening, and for which there are currently limited patient options.

Retrophin is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening, and for which there are currently limited patient options.

Technology Expertise

Backed by a highly experienced management and scientific team, Retrophin is uniquely positioned to identify underutilized assets, conduct new, in-house drug discovery and find the fastest path to approval for its drugs in development.

 

 

Therapeutic Focus

Retrophin is a biopharmaceutical company focused on discovering, developing and marketing innovative therapies for debilitating and often life-threatening diseases.  We are dedicated to working in areas in which the biopharmaceutical industry has, to date, had limited interest or effectiveness.  We maintain a focus on patients, working with doctors and patient advocacy groups and seeking to understand their distinct needs.

 

 

Latest News